Amendment No. 1 to the Exclusive License Agreement, dated April 16, 2013, by and among the Registrant, The Regents of the University of California, and the University of Vienna
Certain identified information has been excluded from this exhibit because it is both not material and is the type that the registrant treats as private or confidential. Information that was omitted has been noted in this document with a placeholder identified by the mark [***].
CARIBOU BIOSCIENCES, INC.
THE UNIVERSITY OF VIENNA
THE REGENTS OF THE UNIVERSITY OF CALIFORNIA
METHODS AND COMPOSITIONS FOR RNA-DIRECTED TARGET DNA MODIFICATION
AND FOR RNA-DIRECTED MODULATION OF TRANSCRIPTION
Caribou Biosciences , Inc. (Caribou), the University of Vienna (University of Vienna) and the Regents of the University of California (Regents) do hereby agree to amend the EXCLUSIVE LICENSE BETWEEN CARIBOU BIOSCIENCES, INC., THE UNIVERSITY OF VIENNA AND THE REGENTS OF THE UNIVERSITY OF CALIFORNIA relating to [***] (Agreement) in the respects shown below (Amendment Agreement):
Section 1.7 of the Agreement shall be deleted and replaced with the following:
1.7 HHMI assigned its rights in the Inventions to REGENTS [***] and accordingly, REGENTS has the authority to negotiate a license on behalf of UNIVERSITY OF VIENNA in the Invention and any patent rights claiming it. REGENTS have no authority to license Emmanuelle Charpentiers interest or rights in the Inventions.
Article 17 of the Agreement shall be deleted and replaced with the following:
[signature page to follow]
IN WITNESS WHEREOF, the parties hereto executed this Amendment Agreement by their duly authorized officers or representatives.
|THE REGENTS OF THE UNIVERSITY OF CALIFORNIA||CARIBOU BIOSCIENCES, INC.|
|Michael Katz||Rachel E. Haurwitz|
|Intellectual Property and Industry Research Alliances|
|THE UNIVERSITY OF VIENNA|
|Vice-Rector for Research and Career Development|